Search by Drug Name or NDC
NDC 71406-0113-01 METOLAZONE 2.5 mg/1 Details
METOLAZONE 2.5 mg/1
METOLAZONE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AACE Pharmaceuticals, Inc.. The primary component is METOLAZONE.
Product Information
| NDC | 71406-0113 |
|---|---|
| Product ID | 71406-113_ece304a3-d30d-1ca6-e053-2a95a90a92ea |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | METOLAZONE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metolazone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | METOLAZONE |
| Labeler Name | AACE Pharmaceuticals, Inc. |
| Pharmaceutical Class | Increased Diuresis [PE], Thiazide-like Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216216 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 71406-0113-01 (71406011301)
| NDC Package Code | 71406-113-01 |
|---|---|
| Billing NDC | 71406011301 |
| Package | 100 TABLET in 1 BOTTLE (71406-113-01) |
| Marketing Start Date | 2021-09-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |